EVMN · Evommune, Inc. · Investor Relations
$7.04
-0.20 (-2.76%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$291.10M
Shares
41.35M
Volume · Nov 20
549.4K
Avg daily vol (3M)
834K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-12-02 15:25 UTC | 9th Annual Evercore Healthcare Conference | Conference |
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-18 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-11-11 | Stifel Healthcare Conference 2026 | Conference |
| 2026-11-11 | Stifel 2026 Healthcare Conference Fireside Chat | Conference |
| 2026-11-05 | EVO570: Potential Best-in-Class VAV1 Molecular Glue Degrader | Event |
| 2026-10-01 | Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress | Presentation |
| 2026-06-02 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-04-13 | KOL Webinar Highlighting Role of MRGPRX2 in Migraine | Event |
| 2026-02-10 | Evommune EVO301 Top-Line Results from Phase 2a Trial in Moderate-to-Severe Atopic Dermatitis | Event |
Source: https://ir.evommune.com/
Key facts
CIK
2044725
CUSIP
30054Y107
13F (30d)
99 filings
97 filers
Visit website
Investor relations